NCT06744465 - NearWave Optical Molecular Monitoring | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Breast CancerHER2-positive Breast CancerTNBC - Triple-Negative Breast CancerHER2-negative Breast CancerInvasive Breast Carcinoma

Interventions

DEVICE

NearWave monitoring

NearWave optical molecular monitoring

Trial Locations (1)

RECRUITING

Indiana University Simon Comprehensive Cancer Center, Indianapolis

All Listed Sponsors

collaborator

University of Notre Dame

OTHER

collaborator

Elevate Ventures

UNKNOWN

collaborator

NearWave Corp.

UNKNOWN

lead

Indiana University

OTHER